Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
Publishing timestamp: 2024-03-10 08:00:01
Summary
Pfizer is shifting focus to cancer drugs to offset losses from Covid products. The company aims to produce at least eight blockbuster medicines by 2030 through its partnership with Seagen. Despite challenges, analysts are optimistic about Pfizer's oncology business strategy and potential growth in the future. Pfizer is also working on developing new vaccines, treatments for diseases like sickle cell and cancer cachexia, and weight loss pills.
Sentiment: MIXED
Keywords: business, merck & co inc, pfizer inc, astellas pharma inc, science, joe biden, pharmaceuticals, biotechnology, breaking news, business news, health care industry, biotech and pharmaceuticals,
Source: https://www.cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html